Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
about
sameAs
Eicosanoid pathway in colorectal cancer: Recent updatesA systematic review of aspirin in primary prevention: is it time for a new approach?Chemoprevention of cancer: current evidence and future prospectsThe evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimismFusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironmentCancer prevention and control: alarming challenges in ChinaPrimary and Secondary Chemoprevention of Malignant Melanoma.Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)Aspirin and other NSAIDs as chemoprevention agents in melanomaInactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancerCorrelation between long-term aspirin use and F-fluorodeoxyglucose uptake in colorectal cancer measured by PET/CT.Role of aspirin in cancer prevention.The utility of Apc-mutant rats in modeling human colon cancer.Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancerChemo/Dietary prevention of cancer: perspectives in ChinaRelationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studiesSubstrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface.Pharmacological and dietary prevention for colorectal cancer.Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenomaAssociation of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.Prevention of colorectal cancer and dietary managementTissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemopreventionProportion of colon cancer attributable to lifestyle in a cohort of US women.Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer PreventionAspirin and Acetaminophen Use and the Risk of Cervical Cancer.Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention.Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trialGenetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.Population-wide Impact of Long-term Use of Aspirin and the Risk for CancerThe impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme.Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study
P2860
Q26778011-1C93F99F-0396-405F-BA17-BD94142730B3Q26864015-77EF9D1D-A718-4C6D-8B62-8223AE6A9CCFQ27000363-86531208-3F48-42CE-B302-159421855F55Q28087427-10A0941F-9FDC-4DC6-AB64-B199B630BA4BQ28296759-042370C6-5637-4665-9241-29A60D03B073Q28396786-CFFAC7BA-9CEE-415F-822D-37FB676FA6FAQ30245112-02E6CCE0-8C9E-4FC8-A8EF-9599DCF49744Q33648694-285E8FD9-4056-4A3E-B08D-5F63CAFB2BC2Q33725012-A61E524C-FC78-45B9-906A-4FF179E18013Q34017114-DB2EB321-7B19-413A-845D-E2DDEEBF51D4Q34296467-F3C69E63-B699-42EF-ABF5-CF7B8A542CB6Q34301588-AC2832E2-5358-45EB-B686-01B65458CD59Q34376832-CC48B4B7-EA0B-4AB8-B09D-6A87D546F7CEQ34424145-C42A1A2B-D688-4875-AA18-C03EFF39069BQ34477434-2CCFFE38-0441-4B4A-8976-CFDAD8889974Q34604351-B6D37EF5-7968-4E85-9B3E-B8A6309CBBDDQ34658238-23719487-5368-4D13-8A40-553F1359EDFAQ35021987-281752B8-1A8A-48E7-9861-4855D3825F6DQ35051366-8B584DF4-C168-4049-9333-6B16DCE10828Q35065261-83441DFB-4645-491E-8F5A-CBB3B172B031Q35133949-248261E1-ECF0-41CE-8367-A04C65FF12C8Q35177880-3118CDB1-6CE2-4FF6-9CF6-20AFD5F5A146Q35246178-ECC571CC-1832-4E89-82D2-08B5F36C19BDQ35557470-C0FCB91A-D5BF-4F99-AE8F-5DFBBC0EED13Q35576759-59FE768C-B73B-40F2-A9B2-D98E0C804E76Q35859243-3EE3D7D5-384C-419F-A217-E4FE27993F21Q35984462-6A187CC3-9394-4363-9C3A-77E2396C26D7Q36035412-CFAABF80-1B55-4A0C-90C2-3D8FFA2E00C9Q36313479-79ABD1EB-76FE-46CD-A128-B76316EE4B96Q36439797-60177CC7-F147-41E5-9121-6C6DB6131BABQ36444733-1F4805DC-9D2B-4FF6-BB72-FAAEEE0AF540Q36503568-23068E6F-5125-4770-AD05-190FC67EF8EBQ36608462-72381921-242C-4B25-84A6-5EE717B23259Q36693257-9F8B6726-CA13-4072-A318-B6E6ED5F799AQ36747550-93BF75D5-EDDD-423F-A358-BB55C869EE8CQ36951740-4597404C-76D1-45CF-93AC-60A4D4989FEFQ36974684-1760403C-7376-48AC-A805-044C0C40360FQ36989392-1655E685-E584-47D6-B81B-F6B0B801401BQ37003382-8650FC84-CA56-4CFC-A41A-6F0403D049CEQ37008340-15896885-3E43-4256-9D78-70CC7F5ACB41
P2860
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@ast
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@en
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@en-gb
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@nl
type
label
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@ast
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@en
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@en-gb
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@nl
altLabel
Aspirin in the chemoprevention of colorectal neoplasia: an overview
@en
prefLabel
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@ast
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@en
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@en-gb
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@nl
P2093
P2860
P50
P3181
P1476
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
@en
Aspirin in the chemoprevention of colorectal neoplasia: an overview
@en
P2093
A. T. Chan
Andrew T Chan
J. A. Baron
John A Baron
Karsten Schrör
M. A. Hull
Nadir Arber
P2860
P3181
P356
10.1158/1940-6207.CAPR-11-0391
P407
P577
2011-11-14T00:00:00Z
2012-02-01T00:00:00Z